FDA Drug Application (021372) for ALOXI by HELSINN HLTHCARE

Back to FDA Applications sponsored by HELSINN HLTHCARE

Application Number021372
Product Number001
FormINJECTABLE;INTRAVENOUS
DosageEQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameALOXI
Active IngredientPALONOSETRON HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient PALONOSETRON HYDROCHLORIDE4


Back to FDA Applications sponsored by HELSINN HLTHCARE